Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Eur J Haematol. 2018 Oct 9;101(6):798–803. doi: 10.1111/ejh.13173

Figure 4:

Figure 4:

Effects of α-thalassemia and HbF level on RBC deformability measured at 290 mmosmol/l (DI 290) after excluding those under HU therapy. SCA patients with alpha-thalassaemia and HbF < 10%: n = 23; SCA patients without alpha-thalassaemia and HbF < 10%: n = 48; SCA patients with alpha-thalassaemia and HbF > 10%: n = 8; SCA patients without alpha-thalassaemia and HbF > 10%: n = 12. ###Different from the three other groups (p < 0.001); *Different from the three other groups (p < 0.001).